NO995429D0 - Use of a secretion vector for fertility control in oral vaccination - Google Patents

Use of a secretion vector for fertility control in oral vaccination

Info

Publication number
NO995429D0
NO995429D0 NO995429A NO995429A NO995429D0 NO 995429 D0 NO995429 D0 NO 995429D0 NO 995429 A NO995429 A NO 995429A NO 995429 A NO995429 A NO 995429A NO 995429 D0 NO995429 D0 NO 995429D0
Authority
NO
Norway
Prior art keywords
fertility control
oral vaccination
secretion vector
secretion
vector
Prior art date
Application number
NO995429A
Other languages
Norwegian (no)
Other versions
NO995429L (en
Inventor
Peter Donner
Werner Goebel
Andreas Demuth
Ivaylo Gentschev
Juergen Hess
Stefan Kaufmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO995429D0 publication Critical patent/NO995429D0/en
Publication of NO995429L publication Critical patent/NO995429L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO995429A 1997-05-07 1999-11-05 Use of a secretion vector for fertility control in oral vaccination NO995429L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (en) 1997-05-07 1997-05-07 Process for the synthesis and secretion of proteins or protein fragments suitable for contraception by attenuated Salmonella or another Gram-negative attenuated vaccine strain to produce an oral vaccination
PCT/EP1998/002679 WO1998050067A2 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination

Publications (2)

Publication Number Publication Date
NO995429D0 true NO995429D0 (en) 1999-11-05
NO995429L NO995429L (en) 2000-01-07

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995429A NO995429L (en) 1997-05-07 1999-11-05 Use of a secretion vector for fertility control in oral vaccination

Country Status (18)

Country Link
EP (1) EP1015023A1 (en)
JP (1) JP2002501507A (en)
KR (1) KR20010012257A (en)
CN (1) CN1255067A (en)
AU (1) AU7910798A (en)
BG (1) BG103850A (en)
BR (1) BR9809244A (en)
CA (1) CA2288602A1 (en)
DE (1) DE19720761A1 (en)
EE (1) EE9900516A (en)
HU (1) HUP0002752A2 (en)
IL (1) IL132521A0 (en)
IS (1) IS5199A (en)
NO (1) NO995429L (en)
PL (1) PL336786A1 (en)
SK (1) SK151799A3 (en)
TR (1) TR199902671T2 (en)
WO (1) WO1998050067A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (en) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Coated microorganism
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
WO2006121165A1 (en) * 2005-05-12 2006-11-16 Ajinomoto Co., Inc. Method for producing protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009684A1 (en) * 1990-11-21 1992-06-11 Washington University Recombinant avirulent salmonella antifertility vaccines
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Also Published As

Publication number Publication date
EE9900516A (en) 2000-06-15
CA2288602A1 (en) 1998-11-12
TR199902671T2 (en) 2000-09-21
EP1015023A1 (en) 2000-07-05
PL336786A1 (en) 2000-07-17
WO1998050067A2 (en) 1998-11-12
WO1998050067A9 (en) 1999-03-25
JP2002501507A (en) 2002-01-15
KR20010012257A (en) 2001-02-15
NO995429L (en) 2000-01-07
AU7910798A (en) 1998-11-27
WO1998050067A3 (en) 2000-06-29
SK151799A3 (en) 2000-06-12
CN1255067A (en) 2000-05-31
IS5199A (en) 1999-09-28
HUP0002752A2 (en) 2000-12-28
BG103850A (en) 2000-05-31
DE19720761A1 (en) 1998-11-12
BR9809244A (en) 2000-06-27
IL132521A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
FI973244A (en) Pharmaceutical preparations for intranasal use
FR2780633B1 (en) ORTHODONTIC APPARATUS FOR MAXIMUM ARC EXPANSION
EP0846088A4 (en) Cement formulation
ID24247A (en) Alignment of single molds
DK0733367T3 (en) Oral olanzapine formulation
IL132947A0 (en) Novel form of s-omeprazole
DE69805250D1 (en) Execution procedure for gentle handover
HUP0001998A3 (en) Arginine silicate inositol complex and use thereof
KR970000228A (en) Oral preparations of S-etodolak
HK1018779A1 (en) Novel substituted (2(1-piperazinyl)ethoxy) methyl
HUP0003737A3 (en) New process for the preparation of omeprazole
LT2000039A (en) Biocontrol agents for control of root diseases
DE69504137D1 (en) Refractory concrete
NO995429L (en) Use of a secretion vector for fertility control in oral vaccination
DE69604037D1 (en) Fireproof pouring nozzle
GB9401712D0 (en) Hairstyling aid
ZA981897B (en) Formualtions for immunological potentiation of vaccines
EP0799614A4 (en) Remedy for ischemic diseases
ITMI950480A0 (en) REFRACTORY BRICK
PL319344A1 (en) Gene of human galactokinase
FR2752737B1 (en) CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE
KR0116161Y1 (en) Brick projuction's calcination furnace
GB2299125B (en) Shuttering
KR970027656U (en) Liner remover
HU9503055D0 (en) Puzzle called "smurfy brick"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application